SCHEMBL4689718

SCHEMBL4689718

COCCN1C(=O)C(Nc2ccc(NC(C)=O)cc2)=C(c2ccccc2)C1=O

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 9/20 0.55
NR1H3 Q13133 9/20 0.55
MAPT P10636 4/20 0.46
POLB P06746 1/20 0.46
KMT2A Q03164 3/20 0.43
GAA P10253 2/20 0.42
MAPK1 P28482 2/20 0.42
GSK3B P49841 1/20 0.42
KDM4E B2RXH2 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
MEN1 O00255 2/20 0.41
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.40
ALOX12 P18054 1/20 0.40
HTT P42858 1/20 0.40
CACNA1B Q00975 1/20 0.40
APBA1 Q02410 1/20 0.40
NAPRT Q6XQN6 1/20 0.40
HSD17B10 Q99714 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5746128 0.94 NR1H2 (0.51) NR1H2NR1H3MAPTPOLBKMT2A
SCHEMBL5737209 0.93 PTGS2 (0.49) NR1H2NR1H3MAPTPOLBKMT2A
SCHEMBL4687894 0.85 NR1H2 (0.76) NR1H2NR1H3MAPTKMT2AMAPK1
SCHEMBL4688674 0.83 NR1H2 (0.56) NR1H2NR1H3MAPTGSK3B
SCHEMBL4688571 0.80 NR1H2 (0.58) NR1H2NR1H3MAPTKMT2AGSK3B
SCHEMBL5790936 0.79 NR1H2 (0.67) NR1H2NR1H3MAPTKMT2AMAPK1
SCHEMBL4689410 0.78 NR1H2 (0.51) NR1H2NR1H3MAPTALDH1A1HTT
SCHEMBL4689452 0.78 NR1H2 (0.72) NR1H2NR1H3MAPTKMT2AGAA
SCHEMBL4692190 0.78 NR1H2 (0.45) NR1H2NR1H3MAPTKMT2AGAA
SCHEMBL4820919 0.78 NR1H2 (0.64) NR1H2NR1H3MAPTKMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1646626-B1 PYRROLE-2, 5-DIONE DERIVATIVES AS LIVER X RECEPTOR MODULATORS ASTRAZENECA AB (SE) 2008-07-02 EP claimed
US-20060235015-A1 Pyrrole-2,5-dione derivatives as liver x receptor modulators ASTRAZENECA AB (SE) 2006-10-19 US claimed
CN-1823061-A Pyrrole-2, 5-dione derivatives as liver X receptor modulators ASTRAZENECA AB (SE) 2006-08-23 CN claimed
EP-1646626-A1 PYRROLE-2, 5-DIONE DERIVATIVES AS LIVER X RECEPTOR MODULATORS AstraZeneca AB (SE) 2006-04-19 EP claimed
WO-2005005417-A1 PYRROLE-2, 5-DIONE DERIVATIVES AS LIVER X RECEPTOR MODULATORS ASTRAZENECA AB (SE) 2005-01-20 WO claimed
US-7432288-B2 Pyrrole-2,5-dione derivatives as Liver X receptor modulators ASTRAZENECA AB (SE) 2008-10-07 US disclosed
EP-1646626-B1 PYRROLE-2, 5-DIONE DERIVATIVES AS LIVER X RECEPTOR MODULATORS ASTRAZENECA AB (SE) 2008-07-02 EP disclosed
US-20060235015-A1 Pyrrole-2,5-dione derivatives as liver x receptor modulators ASTRAZENECA AB (SE) 2006-10-19 US disclosed
CN-1823061-A Pyrrole-2, 5-dione derivatives as liver X receptor modulators ASTRAZENECA AB (SE) 2006-08-23 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060235015-A1 Pyrrole-2,5-dione derivatives as liver x receptor modulators NR1H2, NR1H3, SREBF2 NR1H2 1/4885NR1H3 2/4885MAPT 2190/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.